Tekla Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-88,102	Closed	-$384K	–	197
2021 Q2	$384K	Hold	88,102	–	–	0.01%	184
2021 Q1	$400K	Hold	88,102	–	–	0.01%	189
2020 Q4	$506K	Hold	88,102	–	–	0.02%	191
2020 Q3	$638K	Hold	88,102	–	–	0.02%	190
2020 Q2	$307K	Hold	88,102	–	–	0.01%	216
2020 Q1	$130K	Hold	88,102	–	–	0.01%	208
2019 Q4	$173K	Hold	88,102	–	–	0.01%	206
2019 Q3	$451K	Hold	88,102	–	–	0.02%	174
2019 Q2	$631K	Buy	+88,102	New	+$998K	0.03%	178
2018 Q4	–	Sell	-169,962	Closed	-$1.88M	–	214
2018 Q3	$1.88M	Hold	169,962	–	–	0.07%	160
2018 Q2	$2.28M	Hold	169,962	–	–	0.09%	132
2018 Q1	$2.21M	Sell	169,962 -40,000	-19%	-$497K	0.09%	131
2017 Q4	$1.93M	Hold	209,962	–	–	0.07%	129
2017 Q3	$1.69M	Buy	+209,962	New	+$1.42M	0.06%	127